Psilocybin + CBD 🧠
Wesana Health Granted US FDA Pre-IND Meeting for SANA-013 The majority of patients with traumatic
January 11, 2022
Wesana Health Granted US FDA Pre-IND Meeting for SANA-013 The majority of patients with traumatic
PharmaTher Provides Update on Product Pipeline and Expected Milestones for 2022 Focused on becoming a
MYND Life Sciences Provides Update on Depression Gene Modulation Pathway Patent Application VANCOUVER, BC, Dec. 15,
B.C.’s functional and psychedelic mushroom industry is having a shroom boom Antidepressants are often ineffective
Braxia Scientific Achieves Milestone as Landmark Psilocybin Clinical Trial Commences, Participants Receive First Doses of
COMPASS Pathways announces positive outcome of 25mg COMP360 psilocybin therapy as adjunct to SSRI antidepressants
BetterLife Obtains Positive TD-0148A Data in Preclinical Models of Depression BetterLife Pharma (BETR) found that
Cybin Confirms Scientific Advice Meeting with UK Medical and Healthcare Products Regulatory Agency for Lead
GH Research Announces Successful Outcome of the Phase 2 part of its Phase 1/2 Clinical
GH Research Announces Successful Outcome of the Phase 2 part of its Phase 1/2 Clinical
World’s Largest Mobile Microdosing Study Published in Nature Scientific Reports Quantified Citizen is a platform
Study suggests psychedelics promote positive mental health through increased spirituality and emotion regulation A recent
Ketamine One Partners with Cognetivity Neurosciences in Collaborative Clinical Study on Depression and PTSD VANCOUVER,
COMPASS Pathways announces further positive results from groundbreaking phase IIb trial of investigational COMP360 psilocybin
MindMed and Liechti Lab publish first human data on the interacting effects of an SSRI
Cybin Announces FDA Investigational New Drug and Institutional Review Board Approvals for a Co-Funded Phase
Ayahuasca users report psychological benefits after taking placebo at a ritualistic ceremony An ayahuasca retreat
Parents Are Very Open To Ketamine Therapy For Kids, Study Finds Most parents think they
Allied Corp Progresses Towards Clinical Phase I Trial for Psilonex™ RX Psilocybin Pharma Drug Allied
Discussions With FDA Provide Guidance For Phase IIb Clinical Trial Design For DMT-assisted Therapy For
Cybin Announces Positive CYB003 Data Demonstrating Significant Advantages Over Oral Psilocybin for Treatment of Mental
COMPASS Pathways announces positive topline results from groundbreaking phase IIb trial of investigational COMP360 psilocybin
COMPASS Pathways announces positive topline results from groundbreaking phase IIb trial of investigational COMP360 psilocybin
Blackhawk Growth’s MindBio Therapeutics Completes Safety Milestone In Its Phase 1 Clinical Trials Vancouver, British